Dupilumab treatment for atopic dermatitis is associated with decreased utilization of psychostimulants for attention deficit hyperactivity disorder
Published: 23 November 2022| Version 1 | DOI: 10.17632/pw4k5nrs6d.1
Contributors:
Ahmet Yildirim, Description
Our study suggests that dupilumab treatment for AD is negatively correlated with the utilization of psychostimulants for ADHD
Files
Institutions
West Virginia University
Categories
Dermatology